Marshall Wace North America »

Sarepta Therapeutics shares owned by Marshall Wace North America

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Marshall Wace North America from 13F filings

Historical chart of Marshall Wace North America investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Marshall Wace North America consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Marshall Wace North America

Quarter filed Position value Share count Share price at filing
2021-09-30 $33M 360k 92.48
2021-06-30 $40M 508k 77.74
2021-03-31 $31M 416k 74.53
2020-12-31 $1.6M 9.4k 170.53
2020-06-30 $1.3M 8.0k 160.29
2019-12-31 $7.3M 57k 129.04
2019-09-30 $192k 2.5k 75.42
2019-06-30 $3.8M 25k 151.94
2019-03-31 $27M 223k 119.19
2018-12-31 $19M 173k 109.13
2018-09-30 $25M 157k 161.51
2018-06-30 $37M 280k 132.18
2018-03-31 $27M 366k 74.09
2017-12-31 $14M 245k 55.64
2017-09-30 $17M 378k 45.00
2017-06-30 $449k 13k 33.99